Quest Laboratories Limited (NSE:QUESTLAB)

Market Cap	1.76B
Revenue (ttm)	841.71M
Net Income (ttm)	117.83M
Shares Out	16.39M
EPS (ttm)	8.00
PE Ratio	13.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,200
Average Volume	16,500
Open	109.80
Previous Close	112.00
Day's Range	109.80 - 109.80
52-Week Range	102.00 - 196.80
Beta	n/a
RSI	40.14
Earnings Date	May 30, 2025

About Quest Laboratories

Quest Laboratories Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. The company provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. It also engages in the cont...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 74
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: QUESTLAB

Financial Performance

In 2023, Quest Laboratories's revenue was 825.63 million, an increase of 33.94% compared to the previous year's 616.41 million. Earnings were 100.94 million, an increase of 100.08%.